INCATE

Since INCATE's inception, Roche’s collaboration has been crucial in supporting us in driving innovation in early-stage antibacterial therapies.  Their invaluable insights help us identify the most promising startups and projects, and we couldn't be more grateful for their belief in our mission and work.

The demand for new #antibiotics is growing, yet discovering and bringing them to market remains challenging. Financial incentives, both "push" and "pull," are crucial for driving early research, supporting later-stage clinical development, and ensuring sustainable returns on investment. Could a Netflix-style model provide a viable solution to stimulate this early-stage research? Read it here ➡️ https://lnkd.in/gachXZaT #amr #antimicrobialresistance #research

📢 Attention Phage Therapy Community! The National Institute of Allergy and Infectious Diseases (NIAID) has released a new funding opportunity: RFA-AI-24-069. This Notice of Funding Opportunity (NOFO) invites applications to establish Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP). The CAPT-CEPs aim to drive forward phage therapy by developing essential preclinical assays, tools, and models, with a strong focus on advancing clinical research in this promising area. 🗓 Application Deadline: January 28, 2025 📬 Important: Letters of intent are due 30 days before the deadline. For more details, check out the full information ➡️ https://lnkd.in/ehCeEShP #phagetherapy #phages #innovation

📢 Call out to Research Scientists looking for an opportunity: Invitris is hiring!

Thank you, Guillermo Tramontin, for mentioning INCATE! This partnership with Cavenagh Health reflects a shared commitment to tackling one of today’s most critical health threats: Antimicrobial Resistance (#AMR). Cavenagh Health brings exceptional expertise in advancing life sciences innovation. Together, we're building more than just talented teams — we're creating the networks, resources, and strategies needed to drive lasting impact. The white paper, "Beyond Antibiotics: The Reckoning of Antimicrobial Resistance, A New Biological Frontier," gathers insights from leading biotechs, innovators, and pharmaceutical companies. It’s a powerful call to action for our society and the key stakeholders who can help turn the tide on AMR. #antibiotics #phages #antimicrobialresistance

🚀 INCATE Entrepreneurs Club #4: "It’s Never Too Early to Speak to a Regulator" Are you navigating the complexities of AMR innovation and wondering when to start discussions with regulators? Join our 4th Entrepreneurs Club where we will discuss about the importance of regulatory guidance from the earliest stages of development. This session will bring together experts and entrepreneurs who have successfully collaborated with regulatory bodies. Don't miss out the opportunity to learn best practices, ask questions, and make connections to help bring your AMR innovation to market. 📅 November 19th 2024  🕔 5pm 📍 Online Sign up here ➡️ https://lnkd.in/e_c54PzZ #webinar #regulatory #entrepreneurship #antimicrobialresistance

As a part of our World Phage Week celebration, we would like to share a recent scientific publication featuring our colleague Mercedes Gonzalez Moreno as co-author, along with other esteemed colleagues and mentors. The study highlights a significant advancement in #bacteriophage research, showcasing how phages can be "trained" to enhance their infectivity through an evolutionary platform targeting biofilm-forming bacteria. Curious to know more about it? Read the full paper here ➡️ https://lnkd.in/gR_Pw7GJ #WorldPhageWeek #Phages #AMR #antimicrobialresistance

💥 Our October Newsletter is out! 💥 Highlights: 💪 The Entrepreneurs Club is back! 🖍 The AMR Conference call for abstracts is now open 🚀 ...and more! 📰 Read all about it in INCATE's Newsletter ➡ https://lnkd.in/esjDQD7s Haven't you subscribed yet? Stay up to date, subscribe here ➡https://lnkd.in/dxq4JtMt

Did you know that today, October 22nd, is World Phage Day? This day also marks the beginning of World Phage Week (October 22nd-28th), dedicated to raising awareness about the life-saving potential of #bacteriophages. These naturally occurring viruses specifically target and destroy harmful bacteria, making them a powerful tool in fighting infections. Despite their potency against bacteria, #phages are safe for humans, animals, and the environment and are among the most abundant organisms on Earth. At INCATE, we are proud to support six incredible phage-focused ventures, with even more in the pipeline. We are proud to continue supporting these groundbreaking therapies, as we strongly believe in their potential to transform healthcare. Congratulations to Kinzbio, Fagoterapia LAB S.r.l., OSPT Ltd, Invitris, PHIOGEN, and PhageOne. Keep up the amazing work! #WorldPhageDay #WorldPhageWeek #PhageTherapy 

📢 Only 8 days left to submit your expression of interest for PACE-AMR! What is PACE looking for? PACE-AMR is focused on fostering early-stage in vitro diagnostic solutions that address bacterial infections with significant unmet needs. Selected applicants can receive grant funding for projects lasting up to two years. Funding opportunities: - Up to £300K for technical feasibility studies (TRL 3) - Up to £1M for product development (TRL 4-5) 🗓️ Expression of interest: October 30th, 23:59 GMT Missed the webinar? Don't worry! You can access the recording and presentation here ➡️ https://lnkd.in/ebjXChhU #amr #diagnostic #opencall